Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 0 | 0 | 0 | 0 | 2,378 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,378 |
| Operating Expenses | 18,622 | 17,657 | 15,305 | 12,243 | 12,048 |
| Operating Income | -18,622 | -17,657 | -15,305 | -12,243 | -9,670 |
| Other Income | 603 | 490 | 407 | 326 | 256 |
| Pre-tax Income | -18,019 | -17,167 | -14,898 | -11,917 | -9,414 |
| Net Income Continuous | -18,019 | -17,167 | -14,898 | -11,917 | -9,414 |
| Net Income | $-18,019 | $-17,167 | $-14,898 | $-11,917 | $-9,414 |
| EPS Basic Total Ops | -13.75 | -14.75 | -16.00 | -13.50 | -11.50 |
| EPS Basic Continuous Ops | -13.72 | -14.79 | -16.09 | -13.55 | -11.43 |
| EPS Diluted Total Ops | -13.75 | -14.75 | -16.00 | -13.50 | -11.50 |
| EPS Diluted Continuous Ops | -13.72 | -14.79 | -16.09 | -13.55 | -11.43 |
| EBITDA(a) | $-18,783 | $-17,832 | $-15,515 | $-12,371 | $-9,688 |